10.6084/m9.figshare.8637680.v1 Ravi Potluri Ravi Potluri Sandip Ranjan Sandip Ranjan Hitesh Bhandari Hitesh Bhandari Helen Johnson Helen Johnson Andriy Moshyk Andriy Moshyk Srividya Kotapati Srividya Kotapati MOESM2 of Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma Springer Nature 2019 Advanced melanoma Melanoma Nivolumab Ipilimumab Healthcare cost comparison CheckMate 067 NCT01844505 2019-07-03 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Healthcare_cost_comparison_analysis_of_nivolumab_in_combination_with_ipilimumab_versus_nivolumab_monotherapy_and_ipilimumab_monotherapy_in_advanced_melanoma/8637680 Additional file 2. Unit cost of key resources (2017).